Citizens Reaffirms Market Outperform on Oracle, $285 Price Target

Analyst: Patrick Walravens 1 min read Reproduced verbatim
Rating
Market Outperform
Unchanged
Target
$285
Unchanged
Upside
+97%
ORCL at $145 today
Citizens JMP and Oracle logos

What the analyst said

Citizens analyst Patrick Walravens reiterated a Market Outperform rating and $285 price target on Oracle (NYSE: ORCL).

“While Oracle remains quite levered with $125B in debt and $37B in cash, we continue to view the stock as an attractive opportunity for long-term capital appreciation for a number of reasons, including: 1) Oracle offers a complete stack for enterprise AI across infrastructure, database, and applications, and has introduced 75 agentic applications, 25 of which are enabled by Fusion Claw, which uses a single execution runtime; 2) the company addresses a massive TAM, which was most recently estimated at $745B ($265B in apps and $480B in infrastructure) in 2023, but which we believe could be materially larger today as AI pushes more enterprise workloads toward Oracle’s platform; 3) Oracle is executing well, driving massive acceleration across its infrastructure business, which we expect to reach $82B in FY28, up from $40B in FY27 and $18B in FY26; 4) CFO Hilary Maxson effectively addressed concerns about how Oracle will fund its data center buildout with her guidance, including committing to a final $20B of incremental capital and a net debt to EBITDA ratio below 3.5x by FY29; and 5) we like the leadership of Co-CEOs Clay Magouyrk and Mike Sicilia, the long-term guidance of Founder, Executive Chairman, and CTO Larry Ellison, who owned ~41% of the shares outstanding as of the September 2025 proxy statement, and the financial acumen of Ms.

Maxson.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $145. The 21 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $285 target is 19% above the median.

12-month window: day 0 of 365, closes on October 29, 2027.

Track record

This callOpen: ORCL has not reached $285 yet. This 12-month target is scored on September 9, 2027. Same target as this firm’s September 9, 2026 note, so it is scored there.

Firm track recordToo early to score Citizens JMP: price targets are 12-month calls and fewer than 5 of its targets are a year old. 1 of its 10 open targets have already been reached. How we score

Citizens JMP on Oracle

Citizens JMP price targets on Oracle

4 calls from September 9, 2026 to October 29, 2026. The target stayed at $285. The rating stayed Buy.

Citizens JMP targetORCL share price
  1. October 29, 2026 This noteKept the $285 targetBuy$285
  2. October 2, 2026Kept the $285 targetBuy$285
  3. September 11, 2026Kept the $285 targetBuy$285
  4. September 9, 2026Earliest call shownBuy$285
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.